Adjuvant Pelvic Radiation Therapy vs Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Risk Early-Stage Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
J. Clin. Oncol 2019 Apr 17;[EPub Ahead of Print], ME Randall, V Filiaci, DS McMeekin, V von Gruenigen, H Huang, CM Yashar, RS Mannel, JW Kim, R Salani, PA DiSilvestro, JJ Burke, T Rutherford, NM Spirtos, K Terada, PR Anderson, WR Brewster, W Small, CA Aghajanian, DS MillerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.